mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.04 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.05 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.05 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |